Could better nutrition help fight Slow-Growing tumors?
NCT ID NCT07302100
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study at Strasbourg University Hospital will check the nutritional status of 100 adults with gastroenteropancreatic neuroendocrine tumors. Researchers want to see if malnutrition is linked to worse outcomes. The goal is to understand whether improving nutrition could help patients with these slow-growing cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that tracking and improving nutrition may help patients with slow-growing neuroendocrine tumors live better and longer.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures nutritional status, so it cannot prove that changing diet improves outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a black seed extract boost immunotherapy against a rare cancer?
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Massive study to map Real-World GEP-NET care
- Could a liver artery shot make cancer treatment more effective?
- Double PET scan may unlock secrets of gut tumors
- New registry tracks PRRT outcomes for neuroendocrine cancer patients